Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
US6602864B1 · kind B1 · utility
2Cited by
2References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 3, 1998 |
| Grant date | Aug 5, 2003 |
| Priority date | — |
| Expiry date | Jun 3, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.